Prevalência Genotípica do Papiloma Vírus Humano em Exames Realizados por um Laboratório no Noroeste do Paraná.

Abstract

The work assessed the genotypic prevalences of HPV, because certain genotypes are related with some types of cancers. The dates were obtained by analyzing laboratory reports by PCR methods for the detection of viral DNA (low, intermediary or high risk oncogenic). Data were collected between April 2016 and January 2019. The same ones separated according to age groups, sex and type of viral DNA identified. Analyzed 3.007 reports, 2.630 women (87.4%), among these 78.8% with absence of HPV DNA and 21.2% had the virus. The male reports represented 12.5% (377 reports), of these 77.4% had absence of the virus and 22.6% had positivization. We observed a higher percentage of high-risk viruses in women (10.3%), and low-risk virus in men (14.8%). Low-risk HPVs in women in greater prevalence were 6 and 61, only 6 is contemplated by vaccination, the genotypes associated with the highest risk were types 16, 58 and 66, only the 16 is included in vaccination. In men, HPV types with the highest prevalence were low oncogenic risk and are contemplated by vaccination (types 6 and 11), while those with prevalence associated with high risk were 66 and 58, not contemplated by vaccination. Educational campaigns on HPV, the availability of the vaccine in public health networks are important to promote the reduction of the spread of this virus, there is also the need for the development of new multivalent vaccines.